Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial
NCT00000570 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2013-12-13
Summary
To determine if surfactant administration at birth in infants at high risk for respiratory distress syndrome (RDS) modified the clinical course of the syndrome.
Conditions
- Lung Diseases
- Respiratory Distress Syndrome
Interventions
- DRUG
-
pulmonary surfactant
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Thurman Merritt · University of California, San Diego
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
Eligibility
- Max Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1986-01-31
- Completion
- 1990-06-30
More Related Trials
-
Aerosolized Surfactant in Neonatal RDS
NCT02294630 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fluid Restriction in Respiratory Distress of the Newborn
NCT03120585 ·Status: COMPLETED ·Phase: NA
-
Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates
NCT02074059 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration
NCT00000563 ·Status: COMPLETED ·Phase: PHASE3
-
Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease
NCT05898633 ·Status: COMPLETED ·Phase: PHASE1
-
First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome
NCT01651637 ·Status: COMPLETED ·Phase: PHASE1
-
Optimal Dose of Surfactant for Preterm Infants With Respiratory Distress Syndrome
NCT04984057 ·Status: UNKNOWN ·Phase: NA
-
Surfactant for Neonatal Respiratory Distress Syndrome at High Altitude Areas:a Prospective Cohort Study
NCT03479450 ·Status: UNKNOWN
-
REspiratory MEchanics for Delivering Individualised Exogenous Surfactant
NCT05791331 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Genetic Regulation of Surfactant Deficiency
NCT00828243 ·Status: COMPLETED
-
Clinical Interventions in Respiratory Distress Syndrome and Neonatal Lung Injury - SCOR in Lung Biology and Diseases in Infants and Children
NCT00005683 ·Status: COMPLETED
-
Effects of Flow Magnitude on Cardiorespiratory Stability During Nasal High Flow Therapy in Preterm Infants
NCT05908227 ·Status: RECRUITING ·Phase: NA
-
Surfactant Lavage vs. Bolus Surfactant in Neonates With Meconium Aspiration
NCT00312507 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of High Flow Nasal Cannula Versus Nasal Continuous Positive Airway Pressure
NCT05849116 ·Status: UNKNOWN
-
Surfactant Versus Nasal Continuous Positive Airway Pressure (nCPAP) for Respiratory Distress Syndrome in the Newborn ≥ 35 Weeks of Gestation
NCT01306240 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
NCT06776783 ·Status: RECRUITING ·Phase: PHASE3
-
The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS
NCT03808402 ·Status: COMPLETED
-
Surfactant for Neonatal Respiratory Distress Syndrome(NRDS) and Neonatal Acute Respiratory Distress Syndrome(NARDS)
NCT04777760 ·Status: RECRUITING
-
Fast Assessment of Surfactant Deficiency in Preterm Infants to Speed up Treatment
NCT05638568 ·Status: WITHDRAWN ·Phase: NA
-
Does The Surfactant Administration by Aerosolization Effective?
NCT02825953 ·Status: UNKNOWN ·Phase: NA
-
Extubation Readiness Study in Very Low Birthweight Infants
NCT01471431 ·Status: TERMINATED ·Phase: NA
-
Efficacy of Surfactant and Perinatal Risk Factors in NRDS With Different Gestational Ages
NCT03385863 ·Status: UNKNOWN
-
Surfactant Administration by Insure or Thin Catheter
NCT04445571 ·Status: RECRUITING ·Phase: NA
-
Sustained Aeration of Infant Lungs Trial
NCT02139800 ·Status: COMPLETED ·Phase: NA
-
A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)
NCT02452476 ·Status: COMPLETED ·Phase: PHASE2